Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
[68Ga]Ga‐PSMA‐11 PET/CT for baseline staging of high‐risk prostate cancer: A real‐world study
Saved in:
| Published in: | BJUI Compass |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: [68Ga]Ga‐PSMA‐11 PET/CT for baseline staging of high‐risk prostate cancer: A real‐world study
- Clinical Utility of 68Ga‐DOTATOC Positron Emission Tomography/Computed Tomography in Evaluating Metastatic Lesions of Clear Cell Renal Cell Carcinoma: A Case Report
- Baseline Predictors of Perineural Invasion and Their Relationship With Adverse Histopathological Findings in Radical Prostatectomy Specimens in Prostate Cancer Patients
- Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer
- Real-World Impact of Androgen Deprivation Therapy Intensification on Prostate Cancer Outcome: A Propensity Score-Matched Analysis From a 25-Year Institutional Experience
- Are Big Prostates a Challenge? Correlation Between Prostate Volume and Detection Rate in Fusion Biopsy of the Prostate
- Prostate-Specific Antigen Density as a Predictor of Biochemical Failure Among Prostate Cancer Patients Who Underwent Open Radical Prostatectomy